The present invention relates to pharmaceutical compositions containing compounds of formula 1wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl； R2 is H, C1-6-alkyl； X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2. processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor本發明係關於含有式1化合物之醫藥組合物，其中R1係H、C1-6-烷基、C0-4-烷基-C3-6-環烷基、C1-6-鹵烷基；R2係H、C1-6-烷基；X 係選自由氯離子(chloride)或½二苯甲醯酒石酸根組成之群之陰離子；j 係1或2；該等醫藥組合物之製備方法及其治療與CCR3受體相關之疾病之用途。
